Back to search

Spain· ES:42250

ETOSUXIMIDA FAES 250 mg CAPSULAS DURAS

A medicinal product containing etosuximida, registered in Spain by Faes Farma S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedETOSUXIMIDA FAES 250 mg CAPSULAS DURASATC—REGISTER NO.ES:42250PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
etosuximida
Manufacturer
Faes Farma S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    664233
    30
    EUR 7.54

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Etosuximida in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etosuximida products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Ethosuximid Neuraxpharm, Petinimid
  • Belgium · Zarontin
  • Bulgaria · Petinimid
  • Czechia · Petinimid
  • Germany · Ethosuximid Glenmark, Ethosuximid Neuraxpharm
  • Denmark · Ethosuximide Orifarm, Ethosuximide Strides
  • France · Zarontin
  • United Kingdom (Northern Ireland) · Emeside, Epesri
  • Croatia · Suxital
  • Ireland · Zarontin
  • Italy · Etosuccimide Glenmark, Zarontin
  • Luxembourg · Zarontin
  • Netherlands · Ethosuximide Aurobindo, Ethosuximide Strides
  • Norway · Ethosuximide Orifarm, Ethosuximide Strides
  • Poland · Petinimid
  • Sweden · Ethosuximide Orifarm, Ethosuximide Strides
  • Slovenia · Suxital
  • Slovakia · Petinimid Cps, Petnidan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/551f4f0d-b5f3-48cb-9e97-a82d07b937b0
GET /v1/drugs/551f4f0d-b5f3-48cb-9e97-a82d07b937b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
  "estado": "{\"aut\":-126234000000}",
  "nregistro": "42250",
  "substance": "etosuximida"
}

See everything about etosuximida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.